Patents by Inventor Keith Langley

Keith Langley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metalloproteinase inhibitor
    Publication number: 20050196390
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Application
    Filed: July 19, 2004
    Publication date: September 8, 2005
    Applicants: Amgen Inc., Children's Hospital of Los Angeles
    Inventors: Keith Langley, Yves DeClerck, Thomas Boone
  • Nucleic acid encoding N-acetylmuramidase M1
    Patent number: 5326858
    Abstract: Disclosed are DNA sequences encoding N-acetylmuramidase M1, polypeptide products of recombinant expression of these DNA sequences, peptides whose sequences are based upon the amino acid sequences deduced from these DNA sequences, antibodies specific for such proteins and peptides, procedures for the detection and quantitation of such proteins and nucleic acids related thereto, as well as procedures relating to the development of bacteriolytic methods, therapeutic agents, and compositions utilizing N-acetylmuramidase M1.
    Type: Grant
    Filed: July 28, 1992
    Date of Patent: July 5, 1994
    Assignee: AMGEN Inc.
    Inventors: Henri Lichenstein, Keith Langley, Mark Zukowski